ArriVent BioPharma, Inc. (AVBP) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2022: -$85.11M2023: -$153.19M2024: $257.65M2025: $307.22M$307.22M
2022Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$307.22M+19.2%
2024$257.65M+268.2%
2023-$153.19M-80.0%
2022-$85.11M